论文部分内容阅读
John Wayne肿瘤研究所对黑色素瘤治疗性疫苗的长期临床试验的初步结果表明,该疫苗对晚期转移性黑色素瘤患者的生存率有十分显著的增加。1992年8月初,Donald Morton在Nobel论文集83中公布的最初结果是基于136名治疗的患者与1200名同样严重程度过去患黑色素瘤患者相比较而得出的。
Preliminary results from the John Wayne Cancer Institute’s long-term clinical trial of melanoma therapeutic vaccines indicate that the vaccine has a very significant increase in survival in patients with advanced metastatic melanoma. In early August 1992, the initial results published by Donald Morton in Nobel’s Proceedings 83 were based on the comparison of 136 treated patients with 1,200 patients with melanoma of similar severity.